Evidence map›Paper›PMID 37255310›Full record

ArticleBioinformatics (Oxford, England)2023

Nonlinear data fusion over Entity-Relation graphs for Drug-Target Interaction prediction.

Eugenio Mazzone, Yves Moreau, Piero Fariselli, Daniele Raimondi

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Eugenio MazzoneDepartment of Medical Sciences, University of Torino, 10123 Torino, Italy.
Yves MoreauDepartment of Electrical Engineering, ESAT-STADIUS, KU Leuven, 3001 Leuven, Belgium.
Piero FariselliDepartment of Medical Sciences, University of Torino, 10123 Torino, Italy.ORCID 0000-0003-1811-4762
Daniele RaimondiDepartment of Electrical Engineering, ESAT-STADIUS, KU Leuven, 3001 Leuven, Belgium.ORCID 0000-0003-1157-1899

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

motivationThe prediction of reliable Drug-Target Interactions (DTIs) is a key task in computer-aided drug design and repurposing. Here, we present a new approach based on data fusion for DTI prediction built on top of the NXTfusion library, which generalizes the Matrix Factorization paradigm by extending it to the nonlinear inference over Entity-Relation graphs.

resultsWe benchmarked our approach on five datasets and we compared our models against state-of-the-art methods. Our models outperform most of the existing methods and, simultaneously, retain the flexibility to predict both DTIs as binary classification and regression of the real-valued drug-target affinity, competing with models built explicitly for each task. Moreover, our findings suggest that the validation of DTI methods should be stricter than what has been proposed in some previous studies, focusing more on mimicking real-life DTI settings where predictions for previously unseen drugs, proteins, and drug-protein pairs are needed. These settings are exactly the context in which the benefit of integrating heterogeneous information with our Entity-Relation data fusion approach is the most evident. AVAILABILITY AND IMPLEMENTATION: All software and data are available at https://github.com/eugeniomazzone/CPI-NXTFusion and https://pypi.org/project/NXTfusion/.

Indexed as

Drug DevelopmentSoftwareDrug DesignDrug InteractionsProteinsProteins

Identifiers

PMID37255310
PMCPMC10265447

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.